Company news

Avecho Biotechnology Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Phosphagenics Oxymorphone Patch Success

March 30, 2016

Oxymorphone Pain Relief Patch - Multi-Dose Trial

March 30, 2016

Opioid Patch Program Update

March 30, 2016

June 2014 App 4D Half Yearly Report and Financial Report

March 30, 2016

Enrolments Completed for Phase 2 Acne Treatment Trial

March 30, 2016

December 2013 Appendix 4E - Annual Financial Report

March 30, 2016

Receipt of $2.4m R&D Tax Incentive

March 29, 2016

Phosphagenics Announces Results of TPM/Oxycodone Ph2a Trial

February 11, 2016

R & D Taxation Incentive

February 10, 2016

Positive Results for Weaner Pig Feed Efficiency Trial

February 10, 2016

POH to Proceed with Twice Weekly Oxycodone Patch Development

February 10, 2016

POH Signs Further Deed of Settlement with Final Parties

February 10, 2016

POH signs Development Deal with Global Cosmetic Company

February 10, 2016

POH signs Agreement with Japanese Pharmaceutical Company

February 10, 2016

POH Oxycodone Patch Dosing in Phase 2 Clinical Trial

February 10, 2016

POH Initiates Clinical Program with Oxymorphone TPM Patch

February 10, 2016

POH Decides to Put its BioElixia Cosmetic Brand Up For Sale

February 10, 2016

POH and Metier Tribeca LLC expand cosmetics product range

February 10, 2016

POH and 3M Collaborate to Improve Oxycodone Patch 5 Fold

February 10, 2016

Phosphagenics to Launch Phase 2 Acne Treatment Trial

February 10, 2016

Phosphagenics to Launch New Cellulite Cosmetics

February 10, 2016

Phosphagenics to Launch BodyShaper in UK Market

February 10, 2016

Phosphagenics Signs Deed of Settlement with Dr Ogru

February 10, 2016

Phosphagenics Restructures

February 10, 2016

Phosphagenics PHN Trial Completes Enrolment and Dosing

February 10, 2016

Phosphagenics Oxycodone Patch Resumes Clinical Development

February 10, 2016

Phosphagenics Licenses Diclofenac Gel for Indian Market

February 10, 2016

Phosphagenics Initiates Grower/Finisher Pig Study

February 10, 2016

Phosphagenics Further Expands Pain Portfolio

February 10, 2016

Phosphagenics Extends Agreement with Japanese Partner

February 10, 2016

Phosphagenics $19.3 million Capital raising

February 10, 2016

Phosphagenics Collaboration To Develop Anti-acne Drug

February 10, 2016

Phosphagenics Begins Animal Health & Nutrition Program

February 10, 2016

Phosphagenics Appoints Dr Ross Murdoch as CEO

February 10, 2016

Phosphagenics and Quigley Corp form JV for OTC Products

February 10, 2016

Oxymorphone Patch Program Update

February 10, 2016

Novartis Launches Voveran TPM Gel in India

February 10, 2016

June 2015 Half-year Appendix 4D and Financial report

February 10, 2016

June 2013 Appendix 4D Half Year Financial Report - Accounts

February 10, 2016

June 2012 Half Yearly Report and Financial Report

February 10, 2016

First IND Enabling Study for TPM Oxymorphone Completed

February 10, 2016

Ethics Approval -Topical Phase 2 TPM Oxycodone Patch Trial

February 10, 2016

Development Agreement for TPM Oxymorphone Patch

February 10, 2016

Delivery of Further Positive Oxycodone Patch Trial Results

February 10, 2016

December 2014 Preliminary Final Report and Financial Report

February 10, 2016

Animal Health Nutrition License Agreement signed

February 10, 2016

← Newer news releases

Decks

The 5 newest of 23 decks. Every deck is listed under its year.